{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:38:56Z","timestamp":1791283136685,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Alterations in body shape and composition are associated with HIV\/AIDS. Wasting remains prevalent; increasingly, lipodystrophy is reported. Obesity is also epidemic in the USA. In this study, we sought to characterize the body changes reported by women attending a US urban clinic, and to evaluate contributing factors using inexpensive methods that are readily available in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In an urban Maryland clinic, a cross\u2010section of HIV\u2010infected women were evaluated by self report, anthropomorphic measurements, bioelectric impedance analysis (BIA) and chart review; they were categorized as no change, lipodystrophy, weight loss\/wasting or weight gain\/obesity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and sixty\u2010one women were evaluated: 144 (89%) were African\u2010American; 100 (62%) had used intravenous drugs and 40 (25%) were actively injecting drugs, while 39 (24%) smoked crack. Ninety\u2010five (59%) were on highly active antiretroviral therapy (HAART) for a median period of 11.7 months [interquartile range (IQR)=4.5\u201324.2]. Since starting current HAART or in the previous year, 12 (7.4%) reported lipodystrophy changes, 85 (52.8%) weight gain, 27 (16.8%) overall weight loss, and 37 (23.0%) no change. Lipodystrophy was associated with higher CD4 percentage (<jats:italic>P=<\/jats:italic>0.03), lower frequency of crack use (<jats:italic>P=<\/jats:italic>0.04) and higher educational level (<jats:italic>P=<\/jats:italic>0.03). Weight loss correlated with longer duration of infection (<jats:italic>P=<\/jats:italic>0.01), select BIA results and increased rate of crack use (<jats:italic>P=<\/jats:italic>0.005). Weight gain was associated with higher fat mass (<jats:italic>P=<\/jats:italic>0.005), higher peak viral load (<jats:italic>P=<\/jats:italic>0.02), and lower rate of intravenous drug use (<jats:italic>P=<\/jats:italic>0.03).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Self\u2010reported changes in body shape were common. Obesity and complications of illicit drug use were more prevalent than lipodystrophy in this inner\u2010city population of HIV\u2010positive women.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2005.00284.x","type":"journal-article","created":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T17:21:05Z","timestamp":1120238465000},"page":"245-252","source":"Crossref","is-referenced-by-count":19,"title":["Body shape and composition in HIV\u2010infected women: an urban cohort"],"prefix":"10.1111","volume":"6","author":[{"given":"SL","family":"Karmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RD","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AS","family":"Dobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Keruly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"J","family":"Cofrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199302000-00005"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/314027"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf039"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200210010-00014"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/42.6.1255"},{"key":"e_1_2_6_7_2","unstructured":"KotlerD EngelsonE TheaD. Different body composition changes in men and women with AIDS.Eleventh International Conference on AIDS. Vancouver Canada July1996[Abstract]."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.5.1332"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(00)00432-9"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199705010-00007"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)77775-8"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199813000-00012"},{"key":"e_1_2_6_13_2","first-page":"726","article-title":"An objective case definition of lipodystrophy in HIV\u2010infected adults","volume":"361","author":"Carr A","year":"2003","journal-title":"a case\u2013control study"},{"key":"e_1_2_6_14_2","first-page":"480","article-title":"Practical applications of the HIV lipodystrophy case definition","volume":"13","author":"Puls RL","year":"2003","journal-title":"AIDS Read"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/375883"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(96)91726-8"},{"key":"e_1_2_6_17_2","first-page":"104","article-title":"Clinical trials update in human immunodeficiency virus wasting","volume":"25","author":"Muurahainen N","year":"1998","journal-title":"Semin Oncol"},{"key":"e_1_2_6_18_2","first-page":"2621","article-title":"Incidence of adipose tissue alterations in first\u2010line antiretroviral therapy","volume":"162","author":"Galli M","year":"2002","journal-title":"the LipoICoNa Study"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/135965350300800412","article-title":"Correlates of risk of adipose tissue alterations and their modifications over time in HIV\u20101\u2010infected women treated with antiretroviral therapy","volume":"8","author":"Galli M","year":"2003","journal-title":"Antivir Ther"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200309010-00008"},{"key":"e_1_2_6_21_2","first-page":"1482","article-title":"Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection","volume":"31","author":"Thiebaut R","year":"2000","journal-title":"Aquitaine Cohort, France, 1999. Groupe d'Epidemiologie Clinique du Syndrome d'Immunodeficience Acquise en Aquitaine"},{"key":"e_1_2_6_22_2","first-page":"293","article-title":"Minisymposium on obesity","volume":"22","author":"Kumanyika SK.","year":"2001","journal-title":"overview and some strategic considerations"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00005"},{"key":"e_1_2_6_24_2","first-page":"123","article-title":"The triple threat","volume":"17","author":"Bowen DJ","year":"1991","journal-title":"a discussion of gender, class, and race differences in weight"},{"key":"e_1_2_6_25_2","first-page":"200","article-title":"Racial and ethnic diversity in obesity and other risk factors for cardiovascular disease","volume":"1","author":"Savage PJ","year":"1991","journal-title":"implications for studies and treatment"},{"key":"e_1_2_6_26_2","first-page":"49","article-title":"Bioelectrical impedance analysis (BIA) in HIV infection","volume":"9","author":"Swanson B","year":"1998","journal-title":"principles and clinical applications"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0741-8329(95)02001-2"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004140000154"},{"key":"e_1_2_6_29_2","unstructured":"National Center for HIV SaTPN Division of HIV\/AIDS Prevention (DHP).AIDS Public Information Data Set (APIDS). Atlanta Centers for Disease Control and Prevention (CDC) 2004."},{"key":"e_1_2_6_30_2","first-page":"539","article-title":"Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy","volume":"13","author":"McComsey G","year":"2003","journal-title":"AIDS Read"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199702010-00004"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.5.1016"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/135965350200700306","article-title":"Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV\u2010positive patients","volume":"7","author":"Seminari E","year":"2002","journal-title":"Antivir Ther"},{"key":"e_1_2_6_34_2","first-page":"2093","article-title":"Diagnosis, prediction, and natural course of HIV\u20101 protease\u2010inhibitor\u2010associated lipodystrophy, hyperlipidaemia, and diabetes mellitus","volume":"353","author":"Carr A","year":"1999","journal-title":"a cohort study"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2001.00073.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8223(01)00297-8"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(00)00094-5"},{"key":"e_1_2_6_38_2","first-page":"404","article-title":"Body composition in patients with acquired immunodeficiency syndrome","volume":"17","author":"Sluys TE","year":"1993","journal-title":"a validation study of bioelectric impedance analysis"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(99)00146-X"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2005.00284.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2005.00284.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T15:22:06Z","timestamp":1696951326000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2005.00284.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1111\/j.1468-1293.2005.00284.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2005.00284.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}